Ontunisertib could become the first FDA-approved anti-fibrotic suitable for Crohn’s disease patients with symptomatic ...

PRECAUTIONARY POWER SHUTOFFS IN ITS SERVICE AREA. WELL, CROHN’S DISEASE IS A TYPE OF INFLAMMATORY BOWEL DISEASE THAT AFFECTS AROUND 200,000 AMERICANS EVERY YEAR. KOAT. U-N-M HEALTH EXPERT DOCTOR RASH ...

Crohn’s Disease can affect any part of the gastrointestinal tract, but most commonly targets the terminal ileum and proximal colon. A key characteristic of Crohn’s is transmural involvement, meaning ...

How Does Tremfya Work for Crohn's Disease? Tremfya is a type of medicine called a monoclonal antibody. It works by targeting a protein in your body called interleukin-23 (IL-23). IL-23 is a cytokine ...

UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut ...

Mutations in a gene associated with Crohn's disease have been found to rob critical immune cells of their ability to switch ...

Mirikizumab, an interleukin-23p19 inhibitor, provided early and sustained relief of bowel urgency — an underrecognized and debilitating symptom — in patients with moderate-to-severe Crohn’s disease.

Patients with refractory Crohn’s disease who previously received ustekinumab experienced clinical and endoscopic improvements ...

Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing ...

Scientists at the University of Oxford, have identified how rare populations of abnormal cells drive the formation and ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. It can be difficult to discuss Crohn’s, a type of ...